INTERESTED IN THIS RESEARCH?
Contact our analysts for inquiries, samples, and expert insights.
REPORT OUTLOOK
| Market Size | CAGR | Dominating Region |
|---|---|---|
| USD 4.83 billion | 7.9% | North America |
| By Product | By Technology | By End User |
|---|---|---|
|
|
|
SCOPE OF THE REPORT
Blood Screening Market Overview
Blood screening market size was valued at USD 2.44 billion in 2020 and is projected to reach USD 4.83 billion by 2029, growing at a CAGR of 7.9% from 2022 to 2029.
A blood screening is a laboratory examination of substances contained in your blood. Blood tests may be used to monitor how effectively you’re managing an illness like diabetes or high cholesterol. You might need them for routine check-ups or if you’re sick. The goal of blood screening is to detect infection signs so that infected blood and blood components are not released for clinical use. Blood screening procedures are intended to ensure the safety of blood units, not to alert blood donors of reactive test results. To ensure those blood units are safe, screening donated blood and quarantining blood and blood components are key processes that must be followed. They should either be released for clinical or manufacturing use or discarded based on the screening results. TTIs should be tested in the laboratory on blood samples acquired at the time of donation. All blood tests should be carried out and recorded according to defined methods in laboratories that are fully equipped to do so.
| ATTRIBUTE | DETAILS |
| Study period | 2020-2029 |
| Base year | 2021 |
| Estimated year | 2022 |
| Forecasted year | 2022-2029 |
| Historical period | 2018-2020 |
| Unit | Value (USD Million) |
| Segmentation | By Product, By Technology, By End Use and By Region |
|
By Product  |
|
|
By Technology  |
|
| By End User
 |
|
|
By Region  |
|
Blood screening tests are used to ensure the safety of given blood units and to detect any transfusion transmissible infection (TTI) markers in the blood. Increased blood donations and donors, increased awareness about the safety of donated blood, rising prevalence of infectious illnesses, and many government programmes are some of the primary drivers driving the blood screening industry forward.
Prior to donating blood, blood donors are subjected to screening to prevent the spread of infection. Before blood or blood products are transfused, a number of blood tests are done in laboratories. When blood is donated to a blood bank, it is also carefully screened for dangerous infections like HIV, hepatitis B and C, and syphilis. Several governmental programmes have been launched to ensure that donated blood is screened for transfusion transmissible diseases. Similarly, several sorts of screenings are carried out during pregnancy to detect prenatal disorders.
Increased frequency of infectious diseases, increased number of blood donors, increased healthcare awareness, and increased usage of nucleic acid amplification tests are all important factors driving the global blood screening market forward (NAT). Furthermore, the market has been pushed by the government’s increased healthcare initiatives, rising healthcare expenditures, and technological developments in blood screening technologies. However, market expansion is hampered by issues such as demanding regulatory approvals, a scarcity of skilled labour, and high operational expenses. The worldwide blood screening market is likely to benefit from the development of pathogen reduction technology as well as microbiological screening and multiplexing.
As a result of increased understanding and keen interest in safe blood, considerable discrepancies are developing in emerging countries. The global blood screening market is being propelled forward by rising disease prevalence and an expanding patient pool, notably for infectious diseases. Growth is likely to be fuelled by rising blood demand as well as an increase in the number of healthcare facilities such as clinics and hospitals. Furthermore, government support in the form of blood donation camps, awareness campaigns, and other activities, as well as an increase in the number of blood donors, would help to drive overall market growth.
Because of developments in healthcare systems and the availability of and need for complex surgical procedures such as cardiovascular and transplant surgery, trauma treatment, and cancer and blood disease therapies, the need for donated blood is increasing. Every year, around 235 million major surgeries are performed worldwide, with 63 million being traumatic, over 31 million being cancer-related, and 10 million being related to pregnancy issues. In problematic childbirths, blood transfusions are commonly administered to prepare for childhood acute anaemia, trauma, and congenital maternal blood abnormalities.
Despite an increase in transfusion-transmissible illnesses (TTIs) and a higher prevalence of HIV, hepatitis B, hepatitis C, and syphilis in growing nations such as India, China, and Africa, some issues are limiting the growth of the blood screening market. The lack of expenditure on healthcare infrastructure in emerging nations for blood screening procedures is one of the primary issues inhibiting market growth. The high cost of test instruments, as well as tight regulatory standards, are some of the factors that are projected to stymie industry expansion throughout the forecast period.
Blood Screening Market Segment Analysis
The market is broadly segmented into technology, product, end user and region. The reagents and kits are used to detect the presence of disease-associated antigens in a blood sample, depending on the product. Furthermore, the sector dominated the market due to its high accuracy for blood testing as well as customer cost efficiency. Despite the lower cost of reagents and kits compared to instruments, the segment’s significant share in the market is due to larger volume use of these for tests.
Based on technology, the majority of the blood screening market was acquired by the nucleic acid testing segment, which can be ascribed to the technology’s excellent advantages such as high sensitivity and specificity for early detection. Furthermore, the widespread usage of this technology in blood banks, hospitals, and clinical laboratories helps to enhance their participation. Furthermore, the high level of acceptance of this technology in emerging and developing countries provides significant growth potential in this market. However, the segment’s expansion is hampered by needs such as trained labour and expensive acquisition costs.
Based on end user, the market is segmented into blood banks and hospitals. The majority of the market was dominated by the blood banking segment. Infectious illness testing of donated blood and blood products is a critical safety precaution to protect patients and prevent the spread of dangerous infectious diseases. This segment is growing due to rising blood donation and transfusion-related screenings, increased awareness of transfusion-related infections, and the rising incidence of infectious diseases.
Blood Screening Market Players
Major players such as Grifols, Roche, Abbott Laboratories, Biomérieux, Bio-Rad Laboratories, Inc., Siemens Healthineers, Ortho Clinical Diagnostics, Inc., Thermo Fisher Scientific, Inc., Beckman Coulter, Becton, Dickinson and Company are competing closely and dominating the market.
- Grifols, S.A. is a Spanish multinational pharmaceutical and chemical manufacturer. Principally a producer of blood plasma-based products, a field in which it is the European leader and largest worldwide, the company also supplies devices, instruments, and reagents for clinical testing laboratories.
- Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
- Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a diversified line of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.
Who Should Buy? Or Key stakeholders
- Healthcare Industry
- Blood Banks
- Pharmaceuticals Industry
- Hospitals & Clinics
- Scientific Research and Development
- Investors
- Manufacturing companies
- End user companies
Blood Screening Market Regional Analysis
The global blood screening market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- South America: includes Brazil, Argentina and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
North America dominated the market, followed by Europe. The presence of the major market players in the region, as well as factors such as rising demand for blood donations, rising number of blood donations, rising prevalence of infectious diseases and new pathogens, high-quality infrastructure for hospitals and clinical laboratories, and the presence of the major market players in the region, are all key drivers of market growth in this region.
Key Market Segments: Blood Screening Market
Blood Screening Market by Technology, 2020-2029, (USD Million)
- Nucleic Acid Testing (Nat)
- Elisa
- Rapid Tests
- Western Blot Assay
- Next-Generation Sequencing (Nsg)
Blood Screening Market by Product, 2020-2029, (USD Million)
- Reagents & Kits
- Instruments
- Software & Services
Blood Screening Market by End User, 2020-2029, (USD Million)
- Blood Banks
- Hospitals
Blood Screening Market By Region, 2020-2029, (USD Million)
- North America
- Europe
- Asia Pacific
- South America
- Middle East And Africa
Important Countries In All Regions Are Covered.
Key Question Answered
- What are the growth opportunities related to the adoption of blood screening across major regions in the future?
- What are the new trends and advancements in the blood screening market?
- Which product categories are expected to have highest growth rate in the blood screening market?
- Which are the key factors driving the blood screening market?
- What will the market growth rate, growth momentum or acceleration the market carries during the forecast period?
Table of Content
-
- INTRODUCTION
- MARKET DEFINITION
- MARKET SEGMENTATION
- RESEARCH TIMELINES
- ASSUMPTIONS AND LIMITATIONS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT-MATTER EXPERTS’ ADVICE
- QUALITY CHECKS
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- DATA SOURCES
- DATA MINING
- EXECUTIVE SUMMARY
- MARKET OVERVIEW
- GLOBAL BLOOD SCREENING MARKET OUTLOOK
- MARKET DRIVERS
- MARKET RESTRAINTS
- MARKET OPPORTUNITIES
- IMPACT OF COVID-19 ON GLOBAL BLOOD SCREENING MARKET
- GLOBAL BLOOD SCREENING MARKET OUTLOOK
- GLOBAL BLOOD SCREENING MARKET BY TECHNOLOGY, (USD MILLION)
- NUCLEIC ACID TESTING (NAT)
- ELISA
- RAPID TESTS
- WESTERN BLOT ASSAY
- NEXT-GENERATION SEQUENCING (NSG)
- GLOBAL BLOOD SCREENING MARKET BY PRODUCT, (USD MILLION)
- REAGENTS & KITS
- INSTRUMENTS
- SOFTWARE & SERVICES
- GLOBAL BLOOD SCREENING MARKET BY END USER, (USD MILLION)
- BLOOD BANKS
- HOSPITALS
- GLOBAL BLOOD SCREENING MARKET BY REGION, (USD MILLION)
- INTRODUCTION
- ASIA-PACIFIC
- CHINA
- INDIA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- SOUTH-EAST ASIA
- REST OF ASIA-PACIFIC
- NORTH AMERICA
- UNITED STATES
- CANADA
- MEXICO
- EUROPE
- GERMANY
- UNITED KINGDOM
- FRANCE
- ITALY
- SPAIN
- RUSSIA
- REST OF EUROPE
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- COLOMBIA
- REST OF SOUTH AMERICA
- MIDDLE EAST AND AFRICA
- UAE
- SAUDI ARABIA
- SOUTH AFRICA
- REST OF MIDDLE EAST AND AFRICA
- COMPANY PROFILES* (BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)
- GRIFOLS
- HOFFMANN-LA ROCHE
- ABBOTT LABORATORIES
- BIOMéRIEUX
- BIO-RAD LABORATORIES, INC.
- SIEMENS HEALTHINEERS
- ORTHO CLINICAL DIAGNOSTICS, INC.
- THERMO FISHER SCIENTIFIC, INC.
- BECKMAN COULTER
- BECTON, DICKINSON AND COMPANY
- OTHER *THE COMPANY LIST IS INDICATIVE
LIST OF TABLES
TABLE 1Â Â Â Â Â Â Â Â Â Â Â GLOBAL BLOOD SCREENING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 2Â Â Â Â Â Â Â Â Â Â Â GLOBAL BLOOD SCREENING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 3Â Â Â Â Â Â Â Â Â Â Â GLOBAL BLOOD SCREENING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 4Â Â Â Â Â Â Â Â Â Â Â GLOBAL BLOOD SCREENING MARKET BY REGION (USD MILLIONS) 2020-2029
TABLE 5Â Â Â Â Â Â Â Â Â Â Â US BLOOD SCREENING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 6Â Â Â Â Â Â Â Â Â Â Â US BLOOD SCREENING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 7Â Â Â Â Â Â Â Â Â Â Â US BLOOD SCREENING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 8Â Â Â Â Â Â Â Â Â Â Â CANADA BLOOD SCREENING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 9Â Â Â Â Â Â Â Â Â Â Â CANADA BLOOD SCREENING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 10Â Â Â Â Â Â Â Â Â CANADA BLOOD SCREENING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 11Â Â Â Â Â Â Â Â Â MEXICO BLOOD SCREENING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 12Â Â Â Â Â Â Â Â Â MEXICO BLOOD SCREENING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 13Â Â Â Â Â Â Â Â Â MEXICO BLOOD SCREENING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 14Â Â Â Â Â Â Â Â Â BRAZIL BLOOD SCREENING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 15Â Â Â Â Â Â Â Â Â BRAZIL BLOOD SCREENING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 16Â Â Â Â Â Â Â Â Â BRAZIL BLOOD SCREENING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 17Â Â Â Â Â Â Â Â Â ARGENTINA BLOOD SCREENING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 18Â Â Â Â Â Â Â Â Â ARGENTINA BLOOD SCREENING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 19Â Â Â Â Â Â Â Â Â ARGENTINA BLOOD SCREENING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 20Â Â Â Â Â Â Â Â Â COLOMBIA BLOOD SCREENING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 21Â Â Â Â Â Â Â Â Â COLOMBIA BLOOD SCREENING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 22Â Â Â Â Â Â Â Â Â COLOMBIA BLOOD SCREENING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 23Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA BLOOD SCREENING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 24Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA BLOOD SCREENING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 25Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA BLOOD SCREENING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 26Â Â Â Â Â Â Â Â Â INDIA BLOOD SCREENING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 27Â Â Â Â Â Â Â Â Â INDIA BLOOD SCREENING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 28Â Â Â Â Â Â Â Â Â INDIA BLOOD SCREENING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 29Â Â Â Â Â Â Â Â Â CHINA BLOOD SCREENING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 30Â Â Â Â Â Â Â Â Â CHINA BLOOD SCREENING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 31Â Â Â Â Â Â Â Â Â CHINA BLOOD SCREENING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 32Â Â Â Â Â Â Â Â Â JAPAN BLOOD SCREENING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 33Â Â Â Â Â Â Â Â Â JAPAN BLOOD SCREENING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 34Â Â Â Â Â Â Â Â Â JAPAN BLOOD SCREENING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 35Â Â Â Â Â Â Â Â Â SOUTH KOREA BLOOD SCREENING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 36Â Â Â Â Â Â Â Â Â SOUTH KOREA BLOOD SCREENING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 37Â Â Â Â Â Â Â Â Â SOUTH KOREA BLOOD SCREENING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 38Â Â Â Â Â Â Â Â Â AUSTRALIA BLOOD SCREENING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 39Â Â Â Â Â Â Â Â Â AUSTRALIA BLOOD SCREENING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 40Â Â Â Â Â Â Â Â Â AUSTRALIA BLOOD SCREENING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 41Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA BLOOD SCREENING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 42Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA BLOOD SCREENING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 43Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA BLOOD SCREENING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 44Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC BLOOD SCREENING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 45Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC BLOOD SCREENING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 46Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC BLOOD SCREENING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 47Â Â Â Â Â Â Â Â Â GERMANY BLOOD SCREENING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 48Â Â Â Â Â Â Â Â Â GERMANY BLOOD SCREENING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 49Â Â Â Â Â Â Â Â Â GERMANY BLOOD SCREENING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 50Â Â Â Â Â Â Â Â Â UK BLOOD SCREENING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 51Â Â Â Â Â Â Â Â Â UK BLOOD SCREENING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 52Â Â Â Â Â Â Â Â Â UK BLOOD SCREENING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 53Â Â Â Â Â Â Â Â Â FRANCE BLOOD SCREENING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 54Â Â Â Â Â Â Â Â Â FRANCE BLOOD SCREENING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 55Â Â Â Â Â Â Â Â Â FRANCE BLOOD SCREENING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 56Â Â Â Â Â Â Â Â Â ITALY BLOOD SCREENING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 57Â Â Â Â Â Â Â Â Â ITALY BLOOD SCREENING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 58Â Â Â Â Â Â Â Â Â ITALY BLOOD SCREENING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 59Â Â Â Â Â Â Â Â Â SPAIN BLOOD SCREENING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 60Â Â Â Â Â Â Â Â Â SPAIN BLOOD SCREENING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 61Â Â Â Â Â Â Â Â Â SPAIN BLOOD SCREENING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 62Â Â Â Â Â Â Â Â Â RUSSIA BLOOD SCREENING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 63Â Â Â Â Â Â Â Â Â RUSSIA BLOOD SCREENING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 64Â Â Â Â Â Â Â Â Â RUSSIA BLOOD SCREENING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 65Â Â Â Â Â Â Â Â Â REST OF EUROPE BLOOD SCREENING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 66Â Â Â Â Â Â Â Â Â REST OF EUROPE BLOOD SCREENING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 67Â Â Â Â Â Â Â Â Â REST OF EUROPE BLOOD SCREENING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 68Â Â Â Â Â Â Â Â Â UAE BLOOD SCREENING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 69Â Â Â Â Â Â Â Â Â UAE BLOOD SCREENING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 70Â Â Â Â Â Â Â Â Â UAE BLOOD SCREENING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 71Â Â Â Â Â Â Â Â Â SAUDI ARABIA BLOOD SCREENING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 72Â Â Â Â Â Â Â Â Â SAUDI ARABIA BLOOD SCREENING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 73Â Â Â Â Â Â Â Â Â SAUDI ARABIA BLOOD SCREENING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 74Â Â Â Â Â Â Â Â Â SOUTH AFRICA BLOOD SCREENING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 75Â Â Â Â Â Â Â Â Â SOUTH AFRICA BLOOD SCREENING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 76Â Â Â Â Â Â Â Â Â SOUTH AFRICA BLOOD SCREENING MARKET BY END USER (USD MILLIONS) 2020-2029
TABLE 77Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA BLOOD SCREENING MARKET BY TECHNOLOGY (USD MILLIONS) 2020-2029
TABLE 78Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA BLOOD SCREENING MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 79Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA BLOOD SCREENING MARKET BY END USER (USD MILLIONS) 2020-2029
LIST OF FIGURES
FIGURE 1Â Â Â Â Â Â Â Â Â MARKET DYNAMICS
FIGURE 2Â Â Â Â Â Â Â Â Â MARKET SEGMENTATION
FIGURE 3Â Â Â Â Â Â Â Â Â REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4Â Â Â Â Â Â Â Â Â DATA TRIANGULATION
FIGURE 5Â Â Â Â Â Â Â Â Â BOTTOM-UP APPROACH
FIGURE 6Â Â Â Â Â Â Â Â Â TOP-DOWN APPROACH
FIGURE 7Â Â Â Â Â Â Â Â Â RESEARCH FLOW
FIGURE 8Â Â Â Â Â Â Â Â Â GLOBAL BLOOD SCREENING MARKETBY TECHNOLOGY, USD MILLION, 2020-2029
FIGURE 10Â Â Â Â Â Â Â GLOBAL BLOOD SCREENING MARKETBY PRODUCT, USD MILLION, 2020-2029
FIGURE 11Â Â Â Â Â Â Â GLOBAL BLOOD SCREENING MARKETBY END USER, USD MILLION, 2020-2029
FIGURE 12Â Â Â Â Â Â Â GLOBAL BLOOD SCREENING MARKETBY REGION, USD MILLION, 2020-2029
FIGURE 13       PORTER’S FIVE FORCES MODEL
FIGURE 14Â Â Â Â Â Â Â GLOBAL BLOOD SCREENING MARKETBY TECHNOLOGY, 2020
FIGURE 15Â Â Â Â Â Â Â GLOBAL BLOOD SCREENING MARKETBY PRODUCT 2020
FIGURE 16Â Â Â Â Â Â Â GLOBAL BLOOD SCREENING MARKETBY END USER 2020
FIGURE 17Â Â Â Â Â Â Â BLOOD SCREENING MARKETBY REGION 2020
FIGURE 18Â Â Â Â Â Â Â MARKET SHARE ANALYSIS
FIGURE 19Â Â Â Â Â Â Â GRIFOLS: COMPANY SNAPSHOT
FIGURE 20Â Â Â Â Â Â Â F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT
FIGURE 21Â Â Â Â Â Â Â ABBOTT LABORATORIES: COMPANY SNAPSHOT
FIGURE 22       BIOMéRIEUX: COMPANY SNAPSHOT
FIGURE 23Â Â Â Â Â Â Â BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
FIGURE 24Â Â Â Â Â Â Â SIEMENS HEALTHINEERS: COMPANY SNAPSHOT
FIGURE 25Â Â Â Â Â Â Â ORTHO CLINICAL DIAGNOSTICS, INC.: COMPANY SNAPSHOT
FIGURE 26Â Â Â Â Â Â Â THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
FIGURE 27Â Â Â Â Â Â Â BECKMAN COULTER: COMPANY SNAPSHOT
FIGURE 28Â Â Â Â Â Â Â BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
- INTRODUCTION
FAQ
Blood screening market size was valued at USD 2.44 billion in 2020 and is projected to reach USD 4.83 billion by 2029, growing at a CAGR of 7.9% from 2022 to 2029.
North America held more than 41% of the Blood Screening market revenue share in 2021 and will witness expansion in the forecast period.
Increased frequency of infectious diseases, increased number of blood donors, increased healthcare awareness, and increased usage of nucleic acid amplification tests are all important factors driving the global blood screening market forward (NAT). Furthermore, the market has been pushed by the government’s increased healthcare initiatives, rising healthcare expenditures, and technological developments in blood screening technologies. However, market expansion is hampered by issues such as demanding regulatory approvals, a scarcity of skilled labour, and high operational expenses.
The leading application of Blood Screening market in 2020 was blood banking segment. It has the biggest market share.
North America held the largest market share of Blood Screening market.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.